Hepatitis C Therapy - ALT levels may not give true picture of liver disease in HIV/HCV

ALT levels may not give true picture of liver disease in HIV/HCV
Aidsmap - The majority of HIV-positive individuals coinfected with hepatitis C virus who, according to a key blood test, have normal liver function are, in fact, suffering from mild to severe liver damage, according to an Italian study published in the January

HEPATITIS C TREATMENT IN LATINOS
HispanicBusiness.com - Roche announced today that the company is investing more resources in treating the Latino community by expanding the largest study to date comparing hepatitis C treatment response rates in Latinos and non-Latino Caucasians treated with Pegasys

First-Time Generic Approvals: Copegus, Tegretol, Roxicodone
Medscape News - Jan. 24, 2006 The US Food and Drug Administration (FDA) approved in December 2005 first-time generic 200-mg formulations of ribavirin and carbamazepine tablets, and 15- and 30-mg formulations of oxycodone HCl tablets. First-time doses (ie, no

Schering-Plough Drug Gets Fast Track
MSN MoneyCentral - KENILWORTH, N.J. (AP) - Drug maker Schering-Plough Corp. said Monday that regulators granted "fast track" status to its experimental hepatitis C treatment. The Food and Drug Administration gives the fast track label -- which sometimes helps speed the

Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership
Genetic Engineering News - Inovio Biomedical Corporation (AMEX:INO), a late stage developer of cancer and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has signed an agreement with Swedish-based Tripep AB (The Stockholm